Article Details
Retrieved on: 2024-01-27 00:10:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Navidea Biopharmaceuticals, Inc. announced today the filing of Form 15 to voluntarily deregister and suspend SEC reporting obligations.
Article found on: www.investorsobserver.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here